These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34117052)

  • 1. Molecular-scale spatio-chemical control of the activating-inhibitory signal integration in NK cells.
    Toledo E; Le Saux G; Edri A; Li L; Rosenberg M; Keidar Y; Bhingardive V; Radinsky O; Hadad U; Di Primo C; Buffeteau T; Smith AS; Porgador A; Schvartzman M
    Sci Adv; 2021 Jun; 7(24):. PubMed ID: 34117052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of Nanoscale Arrays to Study the Effect of Ligand Arrangement on Inhibitory Signaling in NK Cells.
    Le Saux G; Toledo-Ashkenazi E; Schvartzman M
    Methods Mol Biol; 2023; 2654():313-325. PubMed ID: 37106191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells' immune response requires a minimal nanoscale distribution of activating antigens.
    Keydar Y; Le Saux G; Pandey A; Avishay E; Bar-Hanin N; Esti T; Bhingardive V; Hadad U; Porgador A; Schvartzman M
    Nanoscale; 2018 Aug; 10(30):14651-14659. PubMed ID: 30033475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based rational design of a novel chimeric PD1-NKG2D receptor for natural killer cells.
    Guo C; Wang X; Zhang H; Zhi L; Lv T; Li M; Lu C; Zhu W
    Mol Immunol; 2019 Oct; 114():108-113. PubMed ID: 31351411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
    Zhang C; Zhang J; Wei H; Tian Z
    Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family.
    Dimasi N; Sawicki MW; Reineck LA; Li Y; Natarajan K; Margulies DH; Mariuzza RA
    J Mol Biol; 2002 Jul; 320(3):573-85. PubMed ID: 12096910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms.
    Du Y; Liu X; Guo SW
    Hum Reprod; 2017 Apr; 32(4):794-810. PubMed ID: 28184445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions.
    Sutherland CL; Chalupny NJ; Cosman D
    Immunol Rev; 2001 Jun; 181():185-92. PubMed ID: 11513139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral inhibitors of NKG2D ligands for tumor surveillance.
    Chávez-Blanco A; Chacón-Salinas R; Dominguez-Gomez G; Gonzalez-Fierro A; Perez-Cardenas E; Taja-Chayeb L; Trejo-Becerril C; Duenas-Gonzalez A
    Expert Opin Ther Targets; 2016 Nov; 20(11):1375-1387. PubMed ID: 27322108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions.
    Malarkannan S
    Semin Immunol; 2006 Jun; 18(3):186-92. PubMed ID: 16737823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells.
    Ryan JC; Naper C; Hayashi S; Daws MR
    Immunol Rev; 2001 Jun; 181():126-37. PubMed ID: 11513134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial and Chemical Surface Guidance of NK Cell Cytotoxic Activity.
    Le Saux G; Edri A; Keydar Y; Hadad U; Porgador A; Schvartzman M
    ACS Appl Mater Interfaces; 2018 Apr; 10(14):11486-11494. PubMed ID: 29557634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illuminating the dynamics of signal integration in Natural Killer cells.
    Pageon SV; Rudnicka D; Davis DM
    Front Immunol; 2012; 3():308. PubMed ID: 23060886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on
    Frazao A; Colombo M; Fourmentraux-Neves E; Messaoudene M; Rusakiewicz S; Zitvogel L; Vivier E; Vély F; Faure F; Dréno B; Benlalam H; Bouquet F; Savina A; Pasmant E; Toubert A; Avril MF; Caignard A
    Cancer Immunol Res; 2017 Jul; 5(7):582-593. PubMed ID: 28576831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
    Cifaldi L; Doria M; Cotugno N; Zicari S; Cancrini C; Palma P; Rossi P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
    Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
    J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.